Last reviewed · How we verify

NCT03365401

Efficiency of Surgical Treatment for Lumbar Spinal Stenosis

Status unknown NA Last updated 7 December 2017
What this trial tests

NA trial testing decompression surgery in Lumbar Spinal Stenosis in 150 participants. Status unknown.

Timeline
1 February 2018
Primary endpoint
1 February 2020
1 February 2020

Quick facts

Lead sponsorPeking University People's Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment150
Start date1 February 2018
Primary completion1 February 2020
Estimated completion1 February 2020

Drugs / interventions tested

Conditions studied

Sponsor

Peking University People's Hospital

Who can join

Adults 50 to 80, any sex, with Lumbar Spinal Stenosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Decompression surgery has proved to be effective for Lumbar Spinal Stenosis (LSS) with persistent pain. But the efficiency of the surgery for degenerated LSS remain uncertain and is the subject of this study. This is a multiple center open-label randomised trial. Patients were randomly allocated to surgical group or a nonoperative group. Because of the procedure , neither patients nor investigators were blinded. The primary outcome is the change of symptom measure by the Oswestry disability index 6, 12, and 24 months after procedure.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Lumbar Spinal Stenosis

Currently open trials in the same condition.

Other Peking University People's Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03365401.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing